Related references
Note: Only part of the references are listed.Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential
Caitlin M. Dugdale et al.
ANNALS OF INTERNAL MEDICINE (2019)
Dolutegravir plus Two Different Prodrugs of Tenofovir to Treat HIV
Willem D. F. Venter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1
A. Ayouba et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Bridging the gap between HIV epidemiology and antiretroviral resistance evolution: Modelling the spread of resistance in South Africa
Anthony Hauser et al.
PLOS COMPUTATIONAL BIOLOGY (2019)
Increasing levels of pretreatment HIV drug resistance and safety concerns for dolutegravir use in women of reproductive age
Seth Chekata Inzaule et al.
AIDS (2019)
Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000-2016: A Pooled Sequence Analysis
Benjamin Chimukangara et al.
ECLINICALMEDICINE (2019)
Quantifying the fitness cost of HIV-1 drug resistance mutations through phylodynamics
Denise Kuhnert et al.
PLOS PATHOGENS (2018)
Cost-effectiveness of public-health policy options in the presence of pretreatment NNRTI drug resistance in sub-Saharan Africa: a modelling study
Andrew N. Phillips et al.
LANCET HIV (2018)
HIV-1 antiretroviral drug resistance patterns in patients failing NNRTI-based treatment: results from a national survey in South Africa
K. Steegen et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2017)
Impact of HIV Drug Resistance on HIV/AIDS-Associated Mortality, New Infections, and Antiretroviral Therapy Program Costs in Sub-Saharan Africa
Andrew N. Phillips et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study
Leigh F. Johnson et al.
PLOS MEDICINE (2017)
Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa
Sylvie Boyer et al.
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV (2016)
Assessing the Paradox Between Transmitted and Acquired HIV Type 1 Drug Resistance Mutations in the Swiss HIV Cohort Study From 1998 to 2012
Wan-Lin Yang et al.
JOURNAL OF INFECTIOUS DISEASES (2015)
Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa
Laura M. Heaton et al.
SEXUALLY TRANSMITTED INFECTIONS (2015)
Persistence of Transmitted HIV-1 Drug Resistance Mutations Associated with Fitness Costs and Viral Genetic Backgrounds
Wan-Lin Yang et al.
PLOS PATHOGENS (2015)
Cohort Profile: The international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa
Matthias Egger et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
Share Paper
